Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin
SEC filing record 1 source field available
Fiscal year end
31 December
Jazz Pharmaceuticals plc has filed 2,121 SEC EDGAR filings since 12 May 2003

SEC filing history

Showing 176-200 of 1,000 matching filings.

Per page
25
Current page
8
144 File 001-33500

144 filing

Filing date
10 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Mar 2025
Reporting date
05 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Mar 2025
Reporting date
05 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Mar 2025
Reporting date
05 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Mar 2025
Reporting date
05 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Mar 2025
Reporting date
05 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Mar 2025
Reporting date
05 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-33500

144 filing

Filing date
07 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-33500

144 filing

Filing date
07 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-33500

144 filing

Filing date
07 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
06 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
05 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-82922

SC TO-C

Filing date
05 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-82922

SC TO-C

Filing date
05 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-33500

144 filing

Filing date
03 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .